Aller au contenu principal
Fermer
Forum CROSSJECT
2,230 (c) EUR
-3,46% 

FR0011716265 ALCJ

Euronext Paris données temps réel
  • ouverture

    2,300

  • clôture veille

    2,310

  • + haut

    2,310

  • + bas

    2,230

  • volume

    281 294

  • capital échangé

    0,54%

  • valorisation

    116 MEUR

  • dernier échange

    02.12.25 / 18:20:30

  • limite à la baisse

    Qu'est-ce qu'une limite à la hausse/baisse ?

    Fermer

    2,120

  • limite à la hausse

    Qu'est-ce qu'une limite à la hausse/baisse ?

    Fermer

    2,340

  • rendement estimé 2025

    -

  • PER estimé 2025

    Qu'est-ce que le PER ?

    Fermer

    -

  • dernier dividende

    A quoi correspond le montant du dernier dividende versé ?

    Fermer

    -

  • date dernier dividende

    -

  • Éligibilité

    Qu'est-ce que le PEA ?

    Fermer

    Qu'est-ce que le PEA-PME ?

    Fermer
  • Risque ESG

    Qu'est-ce que le risque ESG ?

    Fermer

    -

  • + Alerte

  • + Portefeuille

  • + Liste

Retour au sujet CROSSJECT

CROSSJECT : Your words have consequences

02 déc. 2025 22:03

I see the same pattern on this forum every day: the endless looping of complaints, the same handful of people repeating the same grievances, as if somehow the 400th post about delays will alter the outcome. It will not. But what it does alter is the atmosphere around the company.

People underestimate how fragile perception is. One positive remark brought me into Crossject weeks ago. A single comment on Twitter set off a chain of research, conviction, and eventually a seven-figure position. That one spark became a domino, and I have seen the same effect on others. Information flows. Sentiment spreads. Confidence compounds.


The reverse is also true. Someone discovering this forum for the first time can easily be turned off by the whiny, repetitive negativity. Not critical thinking, which is valuable. Not genuine concerns, which matter. I am talking about the emotional leakage, the performative despair, the idea that if you stomp your feet loudly enough, Crossject will somehow fast-forward through the reality of building a highly innovative medical device under tight regulatory oversight. It is childish, and it influences more than you think.

Sentiment is a network effect. Tone travels. Potential buyers get discouraged. Long-term holders get drained. Even the narrative around the company becomes distorted.

The irony is that none of this pressure actually moves the timelines.

No one at Crossject woke up thinking, “Let’s delay things again.” This is what innovation looks like: messy, slow, regulated, and sometimes painful. If you see Crossject for what it truly is, essentially a startup operating inside a pharma framework, then dilution, delays, and developmental friction are not aberrations. They are the price of early involvement.

And if you do not want that price, that is fine. Sell and move on.

But recycling the same bitterness day after day does nothing except poison the room. You are not helping yourself, you are not helping other investors, and you are certainly not helping the company whose success you claim to want.

The people who make the biggest returns in situations like this are the ones who understand that conviction has gravity. What you project has consequences.

Your mindset ripples outward.

And if one positive comment was enough to set a chain in motion, imagine what thousands of small, corrosive remarks can do.


Choose which side of that equation you want to be on.


https://x.com/crossject/status/1995959795959115836

0 réponse

Signaler le message

Fermer

Qui a recommandé ce message ?

Fermer
Retour au sujet CROSSJECT

Mes listes

Cette liste ne contient aucune valeur.
Chargement...